Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 3072

1.

Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.

He S, Barron E, Ishikawa K, Nazari Khanamiri H, Spee C, Zhou P, Kase S, Wang Z, Dustin LD, Hinton DR.

Invest Ophthalmol Vis Sci. 2015 Aug 1;56(9):5579-89. doi: 10.1167/iovs.14-16258.

PMID:
26305530
2.

Systemic and renal hemodynamic effects of intra-arterial radiocontrast.

Calzavacca P, Ishikawa K, Bailey M, May CN, Bellomo R.

Intensive Care Med Exp. 2014 Dec;2(1):32. doi: 10.1186/s40635-014-0032-z. Epub 2014 Dec 16.

3.

Comparison between Monte Carlo simulation and measurement with a 3D polymer gel dosimeter for dose distributions in biological samples.

Furuta T, Maeyama T, Ishikawa KL, Fukunishi N, Fukasaku K, Takagi S, Noda S, Himeno R, Hayashi S.

Phys Med Biol. 2015 Aug 21;60(16):6531-46. doi: 10.1088/0031-9155/60/16/6531. Epub 2015 Aug 12.

PMID:
26266894
4.
5.

Correction: Novel ENU-Induced Mutation in Tbx6 Causes Dominant Spondylocostal Dysostosis-Like Vertebral Malformations in the Rat.

Abe K, Takamatsu N, Ishikawa K, Tsurumi T, Tanimoto S, Sakurai Y, Lisse TS, Imai K, Serikawa T, Mashimo T.

PLoS One. 2015 Jul 29;10(7):e0134527. doi: 10.1371/journal.pone.0134527. eCollection 2015.

6.

M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.

Zhou Y, Yoshida S, Nakao S, Yoshimura T, Kobayashi Y, Nakama T, Kubo Y, Miyawaki K, Yamaguchi M, Ishikawa K, Oshima Y, Akashi K, Ishibashi T.

Invest Ophthalmol Vis Sci. 2015 Jul 1;56(8):4767-77. doi: 10.1167/iovs.14-16012.

PMID:
26218904
7.

Repeated Localized Treatment for Endobronchial Metastasis of Thymic Carcinoma.

Taira N, Kawabata T, Furugen T, Ichi T, Kushi K, Yohena T, Kawasaki H, Ishikawa K.

Am J Case Rep. 2015 Jul 23;16:483-5. doi: 10.12659/AJCR.894072.

8.

Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury.

Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T.

Onco Targets Ther. 2015 Jul 10;8:1701-6. doi: 10.2147/OTT.S86743. eCollection 2015.

9.

Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation.

Aoki Y, Ishikawa K, Miura K, Sugimoto K, Nakayama T, Fujimoto Y, Kobayashi Y.

J Cardiol. 2015 Jul 17. pii: S0914-5087(15)00156-2. doi: 10.1016/j.jjcc.2015.05.006. [Epub ahead of print]

PMID:
26194867
10.

Fabrication of strongly attached hydroxyapatite coating on titanium by hydrothermal treatment of Ti-Zn-PO4 coated titanium in CaCl 2 solution.

Valanezhad A, Tsuru K, Ishikawa K.

J Mater Sci Mater Med. 2015 Jul;26(7):5548. doi: 10.1007/s10856-015-5548-6. Epub 2015 Jul 16.

PMID:
26178647
11.

Results of second-stage screening for skin cancers in Oita Prefecture, Japan.

Kai Y, Ishikawa K, Goto M, Sakai T, Ito A, Shono T, Shimada H, Shimizu F, Goto M, Hatano Y, Okamoto O, Katagiri K, Aono H, Eshima N, Fujiwara S.

J Dermatol. 2015 Jul 16. doi: 10.1111/1346-8138.13016. [Epub ahead of print]

PMID:
26177589
12.

SIRT1 mediated inhibition of VEGF/VEGFR2 signaling by Resveratrol and its relevance to choroidal neovascularization.

Zhang H, He S, Spee C, Ishikawa K, Hinton DR.

Cytokine. 2015 Jul 11. pii: S1043-4666(15)30004-1. doi: 10.1016/j.cyto.2015.06.019. [Epub ahead of print]

PMID:
26174951
13.

Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.

Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y.

J Infect Chemother. 2015 Sep;21(9):623-33. doi: 10.1016/j.jiac.2015.05.014. Epub 2015 Jun 9.

PMID:
26166322
14.

Revisiting Old Players in the Revitalized Field of Cardiovascular Gene Therapy.

Ishikawa K, Hajjar RJ.

J Am Coll Cardiol. 2015 Jul 14;66(2):166-8. doi: 10.1016/j.jacc.2015.04.065. No abstract available.

PMID:
26160632
15.

Response to Letter Regarding Article, "Intracoronary Injection of Large Stem Cells: Size Matters".

Ishikawa K.

Circ Cardiovasc Interv. 2015 Jul;8(7):e002855. doi: 10.1161/CIRCINTERVENTIONS.115.002855. No abstract available.

PMID:
26136422
16.

Characterization of a feruloyl esterase B from Talaromyces cellulolyticus.

Watanabe M, Yoshida E, Fukada H, Inoue H, Tokura M, Ishikawa K.

Biosci Biotechnol Biochem. 2015 Jun 25:1-7. [Epub ahead of print]

PMID:
26110915
17.

A Unique DNA Recombination Mechanism of the Mating/Cell-type Switching of Fission Yeasts: a Review.

Klar AJ, Ishikawa K, Moore S.

Microbiol Spectr. 2014 Oct;2(5). doi: 10.1128/microbiolspec.MDNA3-0003-2014.

PMID:
26104357
18.

Correlation between Morphologic Changes and Autism Spectrum Tendency in Obsessive-Compulsive Disorder.

Kobayashi T, Hirano Y, Nemoto K, Sutoh C, Ishikawa K, Miyata H, Matsumoto J, Matsumoto K, Masuda Y, Nakazato M, Shimizu E, Nakagawa A.

Magn Reson Med Sci. 2015 Jun 23. [Epub ahead of print]

19.

Novel ENU-Induced Mutation in Tbx6 Causes Dominant Spondylocostal Dysostosis-Like Vertebral Malformations in the Rat.

Abe K, Takamatsu N, Ishikawa K, Tsurumi T, Tanimoto S, Sakurai Y, Lisse T, Imai K, Serikawa T, Mashimo T.

PLoS One. 2015 Jun 19;10(6):e0130231. doi: 10.1371/journal.pone.0130231. eCollection 2015.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk